安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Differential expression of SERINC2 in cancers of the breast. - ResearchGate
Analysis of human survival data revealed that expression of SERINC2 in primary tumors of the breast was correlated with distant metastasis-free survival in patients with normal-like
- A retrospective analysis of changes in distant and breast cancer . . .
We identified adjuvant studies in breast cancer (BC) from 2000 to 2020 where the endpoint was DFS We examined change in distant DFS events and the BC-related DFS using univariable and
- Changes in expression of breast cancer tumor biomarkers . . . - PubMed
Purpose: In metastatic breast cancer, differences in expression patterns of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) between the primary tumor (PT) and metastatic site (MET) have been reported
- Machine learning assisted analysis of breast cancer gene expression . . .
S100B gene expression is upregulated in TNBC, also the patients with high S100B expression have a longer distant metastasis free survival, further supporting their role in the suppressed cell migration
- An essential gene signature of breast cancer metastasis reveals . . .
To filter the genes higher in metastasis for genes essential for breast cancer proliferation, we incorporated CRISPR-based data from breast cancer cell lines A significant fraction of genes with higher expression in metastasis versus paired primary were essential by CRISPR
- Changes in expression of breast cancer tumor biomarkers . . . - Springer
In metastatic breast cancer, differences in expression patterns of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) between the primary tumor (PT) and metastatic site (MET) have been reported
- Gene expression profiling in breast cancer - PMC
Abstract In recent years, molecular research has translated into remarkable changes of breast cancer diagnostics and therapeutics Molecular tests such as the 21 gene expression test (Oncotype DX TM) and 70 gene microarray test (MammaPrint ®) have revolutionized the predictive and prognostic tools in the clinic By stratifying the risk of recurrence for patients, the tests are able to provide
- Real-world time trends in overall survival, treatments and patient . . .
This study aims to evaluate whether changes in therapeutic strategies have improved survival of patients diagnosed with hormone receptor positive (HR+), HER2 negative (HER2−) advanced breast cancer (ABC) in real-world
|
|
|